Management of Influenza in Patients with COPD

Risk Stratification and Emergency Referral

Patients with COPD and influenza are at high risk for hospitalization and death due to influenza-related respiratory complications, and the decision to seek emergency care should be based on specific clinical criteria rather than the diagnosis alone 1, 2
The American Thoracic Society recommends that patients with COPD and influenza should go to the emergency room if they exhibit any warning signs including shortness of breath at rest or with minimal activity, painful or difficult breathing, coughing up bloody sputum, confusion or disorientation, respiratory rate >30/min, blood pressure <90/60 mmHg, bilateral chest signs suggesting pneumonia, or failure to improve within 48 hours of starting antiviral therapy 1, 2

Patients should go to the ER immediately if they experience respiratory distress, such as shortness of breath at rest or while doing very little activity, painful or difficult breathing, hemoptysis, altered mental status, or vital sign abnormalities, including respiratory rate >30/min or blood pressure <90/60 mmHg 1, 2
Bilateral chest signs suggesting pneumonia are also an indicator for immediate ER referral 1

The CRB-65 severity assessment tool can be used to guide the decision, with a score of 1-2 indicating consideration of hospital referral, and a score of 3-4 indicating urgent hospital referral 1, 2
The CRB-65 score is calculated based on confusion, respiratory rate >30/min, blood pressure <90/60 mmHg, and age ≥65 years, with 1 point for each criterion 1, 2

Patients experiencing clinical deterioration or acute exacerbation of COPD triggered by influenza should be promptly reassessed and considered for hospital referral, as they are at particularly high risk of hospitalization or death 1, 2

Patients should seek medical re-evaluation if they experience fever persistence for 4-5 days without improvement or worsening, initial improvement followed by high fever and feeling unwell again, no improvement within 48 hours of starting antiviral drugs, or any rapid deterioration following initial consultation 1, 2

Patients with mild symptoms, stable vital signs, CRB-65 score of 0, adequate social support, and ability to access follow-up care may be managed at home, but close monitoring is essential, and patients should be instructed on warning signs that require immediate ER evaluation 1, 2

Clinical judgment supersedes any scoring system, and social circumstances, baseline functional status, and access to care must be factored into the decision to seek emergency care 1, 2